| P2093 | author name string | Robert A Reamer | |
| | Bing Mao | |
| | Robert Hartman | |
| | Zhihong Ge | |
| | Ahmed Abrahim | |
| | Jean Wyvratt | |
| | Dean K Ellison | |
| | Sunil V Prabhu | |
| P2860 | cites work | Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction | Q35824725 |
| | New insights into the mode of action of anti-inflammatory drugs | Q40476391 |
| | Prostaglandin synthase 2. | Q40941854 |
| | Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rationale for selective inhibition and progress to date | Q41002618 |
| | Role of prostaglandin H synthase-2 in prostaglandin E2 formation in rat carrageenin-induced pleurisy. | Q50753986 |
| | Kinetics and mechanism of the alkaline hydrolysis of securinine. | Q52360227 |
| | Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2 | Q56864507 |
| | Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs | Q68014016 |
| | Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts | Q71215736 |
| | The discovery of rofecoxib, [MK 966, Vioxx, 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitor | Q78002544 |
| P433 | issue | 6 | |
| P1104 | number of pages | 13 | |
| P304 | page(s) | 1101-1113 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Journal of Pharmaceutical and Biomedical Analysis | Q15752537 |
| P1476 | title | Examination of rofecoxib solution decomposition under alkaline and photolytic stress conditions | |
| P478 | volume | 28 | |